nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.559	0.691	CbGbCtD
Norfloxacin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.25	0.309	CbGbCtD
Norfloxacin—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.00872	0.0456	CcSEcCtD
Norfloxacin—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0362	CcSEcCtD
Norfloxacin—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0342	CcSEcCtD
Norfloxacin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0342	CcSEcCtD
Norfloxacin—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0337	CcSEcCtD
Norfloxacin—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00618	0.0323	CcSEcCtD
Norfloxacin—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00594	0.0311	CcSEcCtD
Norfloxacin—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00594	0.0311	CcSEcCtD
Norfloxacin—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00546	0.0286	CcSEcCtD
Norfloxacin—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0054	0.0283	CcSEcCtD
Norfloxacin—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00401	0.021	CcSEcCtD
Norfloxacin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00344	0.018	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00325	0.017	CcSEcCtD
Norfloxacin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0149	CcSEcCtD
Norfloxacin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0146	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0142	CcSEcCtD
Norfloxacin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0141	CcSEcCtD
Norfloxacin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0138	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0131	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0127	CcSEcCtD
Norfloxacin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0127	CcSEcCtD
Norfloxacin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0123	CcSEcCtD
Norfloxacin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0123	CcSEcCtD
Norfloxacin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0023	0.012	CcSEcCtD
Norfloxacin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.0116	CcSEcCtD
Norfloxacin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0114	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0113	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0111	CcSEcCtD
Norfloxacin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0107	CcSEcCtD
Norfloxacin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.002	0.0105	CcSEcCtD
Norfloxacin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00997	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00973	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00937	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00932	CcSEcCtD
Norfloxacin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00932	CcSEcCtD
Norfloxacin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00927	CcSEcCtD
Norfloxacin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00927	CcSEcCtD
Norfloxacin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00907	CcSEcCtD
Norfloxacin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00887	CcSEcCtD
Norfloxacin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00854	CcSEcCtD
Norfloxacin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00849	CcSEcCtD
Norfloxacin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00849	CcSEcCtD
Norfloxacin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00807	CcSEcCtD
Norfloxacin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00766	CcSEcCtD
Norfloxacin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00732	CcSEcCtD
Norfloxacin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00729	CcSEcCtD
Norfloxacin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00728	CcSEcCtD
Norfloxacin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00722	CcSEcCtD
Norfloxacin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00719	CcSEcCtD
Norfloxacin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00714	CcSEcCtD
Norfloxacin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00696	CcSEcCtD
Norfloxacin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00683	CcSEcCtD
Norfloxacin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00679	CcSEcCtD
Norfloxacin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00668	CcSEcCtD
Norfloxacin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00665	CcSEcCtD
Norfloxacin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00657	CcSEcCtD
Norfloxacin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00644	CcSEcCtD
Norfloxacin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00633	CcSEcCtD
Norfloxacin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00633	CcSEcCtD
Norfloxacin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00633	CcSEcCtD
Norfloxacin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0063	CcSEcCtD
Norfloxacin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00619	CcSEcCtD
Norfloxacin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00611	CcSEcCtD
Norfloxacin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00606	CcSEcCtD
Norfloxacin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00606	CcSEcCtD
Norfloxacin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00594	CcSEcCtD
Norfloxacin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00586	CcSEcCtD
Norfloxacin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00578	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00552	CcSEcCtD
Norfloxacin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00548	CcSEcCtD
Norfloxacin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00544	CcSEcCtD
Norfloxacin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00541	CcSEcCtD
Norfloxacin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00539	CcSEcCtD
Norfloxacin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00534	CcSEcCtD
Norfloxacin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00527	CcSEcCtD
Norfloxacin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000999	0.00523	CcSEcCtD
Norfloxacin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000991	0.00519	CcSEcCtD
Norfloxacin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000955	0.005	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000948	0.00496	CcSEcCtD
Norfloxacin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00482	CcSEcCtD
Norfloxacin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000916	0.00479	CcSEcCtD
Norfloxacin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000916	0.00479	CcSEcCtD
Norfloxacin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00447	CcSEcCtD
Norfloxacin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000832	0.00435	CcSEcCtD
Norfloxacin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00429	CcSEcCtD
Norfloxacin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00415	CcSEcCtD
Norfloxacin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000767	0.00401	CcSEcCtD
Norfloxacin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00386	CcSEcCtD
Norfloxacin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000731	0.00382	CcSEcCtD
Norfloxacin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00382	CcSEcCtD
Norfloxacin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000726	0.0038	CcSEcCtD
Norfloxacin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000689	0.0036	CcSEcCtD
